Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Trio to tackle HIV
April 2020
SHARING OPTIONS:

GUELPH, Ontario—A five-year project is underway between PlantForm Corporation and scientists at the University of Wisconsin-Madison and Université de Montréal to advance development of antibody treatments for HIV. The research collaboration is supported by a $684,196 grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases. Anti-HIV antibodies will be generated using PlantForm’s vivoXPRESS manufacturing platform, and the project will explore protective immune responses to HIV-1 infection by expanding on work done in a vaccine trial held in Thailand 2003-2006. The researchers will focus on the factors that help eliminate HIV-infected cells via antibody-dependent cell-mediated toxicity (ADCC) and develop an assay that can measure ADCC.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.